Cargando…
Coexistent Breast Cancer and Essential Thrombocythemia: How We Addressed the Therapeutic Challenges
Essential thrombocythemia (ET) occurring with breast cancer is uncommon; the therapeutic approach varies and poses a challenge. A 65-year-old female presented to us after being diagnosed with hormone positive, HER2-negative infiltrating ductal carcinoma. She had a platelet count of 600 thou/cu mm. H...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109582/ https://www.ncbi.nlm.nih.gov/pubmed/30159181 http://dx.doi.org/10.1155/2018/2080185 |